Home
Home

Azasite

2 Risks Facing Merck Today

2 Risks Facing Merck Today
Motley Fool

Merck, InSite Vision amend payment terms of AzaSite license agreement

Merck, InSite Vision amend payment terms of AzaSite license agreement
Yahoo/Fly on the Wall

Justice subpoenas Merck on drug marketing

Justice subpoenas Merck on drug marketing
Fierce Pharma

Inspire's Pink Eye Drug AzaSite Draws Generic Challenge

Inspire's Pink Eye Drug AzaSite Draws Generic Challenge
Motley Fool

News

Inspire Pharmaceuticals' eye drug Azasite fails to meet key goals in midstage studies
Yahoo/AP
»

News

Inspire posts smaller loss as Azasite sales rise
Yahoo/AP
»